Insurance underwriting using genetic information

Introduction

Insurance underwriting using genetic information refers to the process through which insurance companies evaluate an individual's potential health risks by examining genetic information when assessing insurance applications, determining premiums or deciding policy eligibility. Genetic information includes inherited characteristics, gene variations, genetic mutations and biological indicators that may reveal an individual's susceptibility to particular diseases.

Advancements in biotechnology, genetic sequencing and personalised medicine have made genetic information increasingly accessible. Insurance companies may consider whether genetic characteristics indicate an increased likelihood of developing inherited disorders, cardiovascular diseases, cancers or other medical conditions.

However, the use of genetic information in insurance underwriting raises significant legal and ethical concerns. Individuals may face discrimination because of genetic characteristics even when they are currently healthy. It may also discourage people from undergoing genetic testing because they fear that their results could affect future insurance coverage.

Therefore, insurance underwriting using genetic information requires a balance between legitimate risk assessment, privacy protection, equality and the prevention of genetic discrimination.

Legal Framework Governing Genetic Information In Insurance Underwriting

In India, insurance underwriting involving genetic information operates within the framework of constitutional protections, insurance regulations, data protection legislation and consumer protection laws.

1. Constitution of India

Article 14 guarantees equality before the law and equal protection of laws. Article 21 protects life and personal liberty, including the right to privacy.

These constitutional protections are relevant when insurance companies collect or use sensitive genetic information in ways that may result in unfair discrimination.

2. Digital Personal Data Protection Act, 2023

The DPDP Act establishes obligations concerning the processing of digital personal data. Genetic information linked to an identifiable individual may fall within its scope.

Insurance companies processing such information must comply with applicable requirements concerning lawful processing, security safeguards and individual rights.

3. Insurance Act, 1938

The Insurance Act provides the statutory framework for insurance business in India. Insurance companies must operate according to applicable regulatory requirements and contractual obligations.

4. IRDAI Regulations

IRDAI supervises insurance companies and regulates insurance products, policyholder protection and insurance-sector practices.

Underwriting practices must comply with applicable regulatory requirements, including requirements concerning fair treatment, transparency and disclosure.

Role Of Genetic Information In Insurance Underwriting

Genetic information may influence insurance risk assessment in several ways.

1. Assessment Of Inherited Disease Risks

Genetic testing may identify inherited variations associated with particular medical conditions. Insurers may consider medical information when evaluating applications, subject to applicable laws and policy requirements.

However, a genetic predisposition does not establish that an individual will necessarily develop a disease.

2. Premium Determination

Insurance companies traditionally calculate premiums by evaluating age, medical history, occupation and other relevant risk factors.

The use of genetic information could potentially influence premium calculations, but such use raises concerns about fairness, discrimination and the scientific interpretation of genetic findings.

3. Policy Eligibility

Insurers may assess medical risks when deciding whether to issue particular policies. Using genetic test results to deny coverage creates significant ethical and legal concerns, particularly where the applicant has no symptoms or diagnosed condition.

4. Predictive Risk Assessment

Genetic information may help identify potential future health risks. However, genetic predictions have limitations because disease development may depend on environmental conditions, lifestyle, family history and other biological factors.

Legal And Ethical Challenges

Insurance underwriting using genetic information creates several important legal challenges.

Genetic discrimination: Individuals may face higher premiums or rejection because of inherited genetic characteristics.

Privacy violations: Genetic information may reveal highly personal details about an individual and biological relatives.

Lack of scientific certainty: A genetic variation may indicate susceptibility rather than certainty of developing a disease.

Informed consent: Individuals may not fully understand the potential consequences of sharing genetic information with insurance companies.

Unequal access to insurance: Genetic underwriting may disadvantage individuals with inherited medical risks, creating barriers to affordable healthcare protection.

Familial implications: Genetic information about one individual may also reveal potential health risks concerning biological relatives who have not consented to its disclosure.

Important Case Laws

There is no established Indian Supreme Court judgment directly deciding whether an insurer may use genetic test results for underwriting. However, several judicial decisions provide important principles concerning privacy, equality, insurance disclosure and medical information.

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 of the Constitution.

The judgment established important principles concerning informational privacy, personal autonomy and protection of sensitive personal information.

Its relevance to genetic underwriting is significant because genetic information is highly personal and may reveal inherited health characteristics. Insurance companies should therefore handle such information within applicable privacy and data protection requirements.

2. National Insurance Co. Ltd. v. Hindustan Safety Glass Works Ltd. (1996) 5 SCC 468

The Supreme Court examined principles concerning insurance contracts and the interpretation of contractual obligations.

The decision is relevant to underwriting disputes because insurance companies must rely on applicable contractual provisions when determining the rights and responsibilities of policyholders.

It does not directly establish rules concerning genetic disclosure, but its contractual principles may assist in analysing disputes involving medical information and insurance applications.

3. LIC of India v. Consumer Education and Research Centre (1995) 5 SCC 482

The Supreme Court examined fairness and constitutional principles in the insurance sector.

The judgment recognised that insurance-related practices may be examined in light of constitutional protections and the requirement of fairness.

It is relevant to genetic underwriting because discriminatory practices based on inherited characteristics may raise concerns about equality and fair access to insurance.

4. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court explained the importance of informed consent in medical treatment.

The judgment is relevant to genetic underwriting because individuals should understand the nature and consequences of medical procedures and the handling of sensitive medical information.

Although it does not directly govern insurance underwriting, its informed-consent principles provide useful guidance for the ethical collection of genetic information.

5. Sharda v. Dharmpal (2003) 4 SCC 493

The Supreme Court considered the relationship between medical examination, individual rights and judicial authority.

The decision is relevant to discussions concerning medical examinations and personal autonomy. It provides a broader legal context for examining disputes involving access to sensitive medical information.

It does not establish a general right for insurers to demand genetic testing.

Responsibilities Of Insurance Companies

Insurance companies using medical and genetic information should adopt responsible underwriting practices.

Their responsibilities include:

Protecting the confidentiality of genetic information.

Avoiding unjustified discrimination based on inherited characteristics.

Ensuring that underwriting decisions rely on scientifically relevant information.

Maintaining appropriate data security systems.

Explaining relevant policy conditions and disclosure requirements.

Complying with applicable data protection and insurance regulations.

Establishing procedures for challenging inaccurate underwriting decisions.

Insurers should also distinguish between an existing diagnosed disease and a genetic predisposition that may never develop into a medical condition.

International Legal Developments

Several international legal frameworks provide useful comparisons for regulating genetic information in insurance.

United States – Genetic Information Nondiscrimination Act, 2008 (GINA): This legislation restricts the use of genetic information in health insurance and employment. Its protections generally do not extend to life, disability and long-term care insurance.

European Union – General Data Protection Regulation (GDPR): Genetic data is classified as a special category of personal data under Article 9, subject to specific processing restrictions and exceptions.

United Kingdom – Genetic testing and insurance framework: The UK has developed an approach under which insurers generally agree not to require or use predictive genetic test results, subject to the terms and exceptions of the applicable Concordat and Moratorium on Genetics and Insurance.

These developments demonstrate the importance of establishing clear safeguards against genetic discrimination.

Conclusion

Insurance underwriting using genetic information represents an emerging legal challenge at the intersection of biotechnology, insurance law, medical ethics and data protection. Although genetic information may provide insights into inherited health risks, its use in insurance decisions creates concerns regarding privacy, discrimination and unequal access to insurance.

In India, constitutional privacy protections, the DPDP Act, 2023, insurance regulations and consumer protection principles provide an important foundation for addressing these concerns.

A comprehensive regulatory framework should establish clear restrictions on genetic data collection, transparent underwriting standards, scientific safeguards and effective remedies against discriminatory insurance practices. Such measures can protect individual rights while allowing responsible development of modern insurance systems.